AstraZeneca has agreed to sell part of its antibiotics business to Pfizer for up to $1.575 billion plus royalties, giving Pfizer the right to sell three approved drugs and two now in clinical trials in most markets outside the U.S.
from WSJ.com: US Business http://ift.tt/2blUseV
via IFTTT
No comments:
Post a Comment